FDA approves Epidiolex derived from marijuana, for severe epilepsy
28 June 2018 | By European Pharmaceutical Review
The FDA has approved Epidiolex oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy...
List view / Grid view
Cannabinoids
Cannabinoid topical cream for treatment of Female Hypoactive Sexual Desire Disorder
27 June 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Pivot Pharmaceuticals Inc. is to begin human clinical trials of PVT-005, the pharmaceutical drug candidate for the treatment of HSDD...
Treating Obstructive Sleep Apnea using cannabinoid-based drugs
7 June 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Therapix Biosciences Ltd, have announced that the first subject was enrolled for its Phase IIa, a sponsor-initiated clinical trial for Obstructive Sleep Apnea...
CBD significantly reduces seizures in patients with severe epilepsy
21 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Cannabidiol was shown in a new large-scale, randomised, controlled trial to significantly reduce the number of dangerous seizures in patients with a severe form of epilepsy...
Hemp shows potential for treating ovarian cancer
24 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers demonstrate hemp's ability to slow cancer growth and uncover mechanism for its cancer-fighting ability...
First-in-Human trial of cannabis-based therapy for Parkinson’s initiated
12 April 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
GB Sciences, Inc. is planning to file an Exploratory IND and perform a Phase 0 Clinical Trial to gather valuable First-In-Human data on its proprietary cannabis-based therapies...
Medicinal cannabis is safe and effective — it’s time to reboot research
19 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers are calling for medicinal cannabis to be properly established in our modern medical arsenal...
CBD may help curb frequency of epileptic seizures
8 March 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A naturally occurring compound found in cannabis may help to curb the frequency of epileptic seizures...
Medical cannabis significantly safer for elderly with chronic pain than opioids
14 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Researchers have found that cannabis therapy is safe and efficacious for elderly patients who are seeking to address cancer symptoms, Parkinson's disease, Crohn's disease and other medical issues...
Cannabidiol may help to reduce seizures in Lennox-Gastaut syndrome
25 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Treatment with a pharmaceutical formulation of cannabidiol alongside other anti-epilepsy treatments helped to reduce the number of drop seizures in people with Lennox-Gastaut syndrome...
CBD may protect against psychiatric risk from high-THC cannabis strains
7 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Neuroscientists have found that cannabidiol reduces symptoms such as impaired memory in adolescent mice simultaneously exposed to THC...
Puration announces strategy to become cannabis market leader
28 July 2017 | By Steve Bremer (European Pharmaceutical Review)
Puration plans to displace pharmaceutical market leader, GW Pharmaceuticals, as part of strategy to grow US cannabis market
Cannabinoids suitable for migraine prevention
29 June 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
A study has confirmed that cannabinoids are just as suitable as a prophylaxis for migraine attacks as other pharmaceutical treatments.
Follow: